A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer

Clinical trial NCT01925274 · TERMINATED

Trial details

NCT number: NCT01925274
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2013-11-15
Primary completion: 2016-04-06
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.